Global HER2 Antibody Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global HER2 Antibody market size was valued at USD 14390 million in 2023 and is forecast to a readjusted size of USD 23030 million by 2030 with a CAGR of 6.9% during review period.
HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy.
Monoclonal antibodies targeting HER2 (human epidermal growth factor receptor 2) are used in the treatment of HER2-positive breast cancer. Market trends include the development of next-generation HER2-targeted therapies and combination therapies to enhance treatment efficacy.
The Global Info Research report includes an overview of the development of the HER2 Antibody industry chain, the market status of Hospital (Trastuzumab, Lapatinib), Medical Center (Trastuzumab, Lapatinib), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of HER2 Antibody.
Regionally, the report analyzes the HER2 Antibody markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global HER2 Antibody market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the HER2 Antibody market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the HER2 Antibody industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Trastuzumab, Lapatinib).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the HER2 Antibody market.
Regional Analysis: The report involves examining the HER2 Antibody market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the HER2 Antibody market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to HER2 Antibody:
Company Analysis: Report covers individual HER2 Antibody players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards HER2 Antibody This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Medical Center).
Technology Analysis: Report covers specific technologies relevant to HER2 Antibody. It assesses the current state, advancements, and potential future developments in HER2 Antibody areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the HER2 Antibody market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
HER2 Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe HER2 Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of HER2 Antibody, with revenue, gross margin and global market share of HER2 Antibody from 2019 to 2024.
Chapter 3, the HER2 Antibody competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and HER2 Antibody market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of HER2 Antibody.
Chapter 13, to describe HER2 Antibody research findings and conclusion.
HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy.
Monoclonal antibodies targeting HER2 (human epidermal growth factor receptor 2) are used in the treatment of HER2-positive breast cancer. Market trends include the development of next-generation HER2-targeted therapies and combination therapies to enhance treatment efficacy.
The Global Info Research report includes an overview of the development of the HER2 Antibody industry chain, the market status of Hospital (Trastuzumab, Lapatinib), Medical Center (Trastuzumab, Lapatinib), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of HER2 Antibody.
Regionally, the report analyzes the HER2 Antibody markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global HER2 Antibody market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the HER2 Antibody market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the HER2 Antibody industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Trastuzumab, Lapatinib).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the HER2 Antibody market.
Regional Analysis: The report involves examining the HER2 Antibody market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the HER2 Antibody market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to HER2 Antibody:
Company Analysis: Report covers individual HER2 Antibody players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards HER2 Antibody This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Medical Center).
Technology Analysis: Report covers specific technologies relevant to HER2 Antibody. It assesses the current state, advancements, and potential future developments in HER2 Antibody areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the HER2 Antibody market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
HER2 Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Trastuzumab
- Lapatinib
- Ado-trastuzumab Emtansine
- Pertuzumab
- Everolimus
- Hospital
- Medical Center
- Genentech Inc
- Novartis AG
- Pfizer
- Abnova Corporation
- InvivoGen
- Celltrion
- Biocon Limited
- Bio-Techne
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe HER2 Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of HER2 Antibody, with revenue, gross margin and global market share of HER2 Antibody from 2019 to 2024.
Chapter 3, the HER2 Antibody competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and HER2 Antibody market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of HER2 Antibody.
Chapter 13, to describe HER2 Antibody research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of HER2 Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Classification of HER2 Antibody by Type
1.3.1 Overview: Global HER2 Antibody Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global HER2 Antibody Consumption Value Market Share by Type in 2023
1.3.3 Trastuzumab
1.3.4 Lapatinib
1.3.5 Ado-trastuzumab Emtansine
1.3.6 Pertuzumab
1.3.7 Everolimus
1.4 Global HER2 Antibody Market by Application
1.4.1 Overview: Global HER2 Antibody Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Medical Center
1.5 Global HER2 Antibody Market Size & Forecast
1.6 Global HER2 Antibody Market Size and Forecast by Region
1.6.1 Global HER2 Antibody Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global HER2 Antibody Market Size by Region, (2019-2030)
1.6.3 North America HER2 Antibody Market Size and Prospect (2019-2030)
1.6.4 Europe HER2 Antibody Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific HER2 Antibody Market Size and Prospect (2019-2030)
1.6.6 South America HER2 Antibody Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa HER2 Antibody Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Genentech Inc
2.1.1 Genentech Inc Details
2.1.2 Genentech Inc Major Business
2.1.3 Genentech Inc HER2 Antibody Product and Solutions
2.1.4 Genentech Inc HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Genentech Inc Recent Developments and Future Plans
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG HER2 Antibody Product and Solutions
2.2.4 Novartis AG HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis AG Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer HER2 Antibody Product and Solutions
2.3.4 Pfizer HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Abnova Corporation
2.4.1 Abnova Corporation Details
2.4.2 Abnova Corporation Major Business
2.4.3 Abnova Corporation HER2 Antibody Product and Solutions
2.4.4 Abnova Corporation HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Abnova Corporation Recent Developments and Future Plans
2.5 InvivoGen
2.5.1 InvivoGen Details
2.5.2 InvivoGen Major Business
2.5.3 InvivoGen HER2 Antibody Product and Solutions
2.5.4 InvivoGen HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 InvivoGen Recent Developments and Future Plans
2.6 Celltrion
2.6.1 Celltrion Details
2.6.2 Celltrion Major Business
2.6.3 Celltrion HER2 Antibody Product and Solutions
2.6.4 Celltrion HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Celltrion Recent Developments and Future Plans
2.7 Biocon Limited
2.7.1 Biocon Limited Details
2.7.2 Biocon Limited Major Business
2.7.3 Biocon Limited HER2 Antibody Product and Solutions
2.7.4 Biocon Limited HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biocon Limited Recent Developments and Future Plans
2.8 Bio-Techne
2.8.1 Bio-Techne Details
2.8.2 Bio-Techne Major Business
2.8.3 Bio-Techne HER2 Antibody Product and Solutions
2.8.4 Bio-Techne HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bio-Techne Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global HER2 Antibody Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of HER2 Antibody by Company Revenue
3.2.2 Top 3 HER2 Antibody Players Market Share in 2023
3.2.3 Top 6 HER2 Antibody Players Market Share in 2023
3.3 HER2 Antibody Market: Overall Company Footprint Analysis
3.3.1 HER2 Antibody Market: Region Footprint
3.3.2 HER2 Antibody Market: Company Product Type Footprint
3.3.3 HER2 Antibody Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global HER2 Antibody Consumption Value and Market Share by Type (2019-2024)
4.2 Global HER2 Antibody Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global HER2 Antibody Consumption Value Market Share by Application (2019-2024)
5.2 Global HER2 Antibody Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America HER2 Antibody Consumption Value by Type (2019-2030)
6.2 North America HER2 Antibody Consumption Value by Application (2019-2030)
6.3 North America HER2 Antibody Market Size by Country
6.3.1 North America HER2 Antibody Consumption Value by Country (2019-2030)
6.3.2 United States HER2 Antibody Market Size and Forecast (2019-2030)
6.3.3 Canada HER2 Antibody Market Size and Forecast (2019-2030)
6.3.4 Mexico HER2 Antibody Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe HER2 Antibody Consumption Value by Type (2019-2030)
7.2 Europe HER2 Antibody Consumption Value by Application (2019-2030)
7.3 Europe HER2 Antibody Market Size by Country
7.3.1 Europe HER2 Antibody Consumption Value by Country (2019-2030)
7.3.2 Germany HER2 Antibody Market Size and Forecast (2019-2030)
7.3.3 France HER2 Antibody Market Size and Forecast (2019-2030)
7.3.4 United Kingdom HER2 Antibody Market Size and Forecast (2019-2030)
7.3.5 Russia HER2 Antibody Market Size and Forecast (2019-2030)
7.3.6 Italy HER2 Antibody Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific HER2 Antibody Consumption Value by Type (2019-2030)
8.2 Asia-Pacific HER2 Antibody Consumption Value by Application (2019-2030)
8.3 Asia-Pacific HER2 Antibody Market Size by Region
8.3.1 Asia-Pacific HER2 Antibody Consumption Value by Region (2019-2030)
8.3.2 China HER2 Antibody Market Size and Forecast (2019-2030)
8.3.3 Japan HER2 Antibody Market Size and Forecast (2019-2030)
8.3.4 South Korea HER2 Antibody Market Size and Forecast (2019-2030)
8.3.5 India HER2 Antibody Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia HER2 Antibody Market Size and Forecast (2019-2030)
8.3.7 Australia HER2 Antibody Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America HER2 Antibody Consumption Value by Type (2019-2030)
9.2 South America HER2 Antibody Consumption Value by Application (2019-2030)
9.3 South America HER2 Antibody Market Size by Country
9.3.1 South America HER2 Antibody Consumption Value by Country (2019-2030)
9.3.2 Brazil HER2 Antibody Market Size and Forecast (2019-2030)
9.3.3 Argentina HER2 Antibody Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa HER2 Antibody Consumption Value by Type (2019-2030)
10.2 Middle East & Africa HER2 Antibody Consumption Value by Application (2019-2030)
10.3 Middle East & Africa HER2 Antibody Market Size by Country
10.3.1 Middle East & Africa HER2 Antibody Consumption Value by Country (2019-2030)
10.3.2 Turkey HER2 Antibody Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia HER2 Antibody Market Size and Forecast (2019-2030)
10.3.4 UAE HER2 Antibody Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 HER2 Antibody Market Drivers
11.2 HER2 Antibody Market Restraints
11.3 HER2 Antibody Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 HER2 Antibody Industry Chain
12.2 HER2 Antibody Upstream Analysis
12.3 HER2 Antibody Midstream Analysis
12.4 HER2 Antibody Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of HER2 Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Classification of HER2 Antibody by Type
1.3.1 Overview: Global HER2 Antibody Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global HER2 Antibody Consumption Value Market Share by Type in 2023
1.3.3 Trastuzumab
1.3.4 Lapatinib
1.3.5 Ado-trastuzumab Emtansine
1.3.6 Pertuzumab
1.3.7 Everolimus
1.4 Global HER2 Antibody Market by Application
1.4.1 Overview: Global HER2 Antibody Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Medical Center
1.5 Global HER2 Antibody Market Size & Forecast
1.6 Global HER2 Antibody Market Size and Forecast by Region
1.6.1 Global HER2 Antibody Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global HER2 Antibody Market Size by Region, (2019-2030)
1.6.3 North America HER2 Antibody Market Size and Prospect (2019-2030)
1.6.4 Europe HER2 Antibody Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific HER2 Antibody Market Size and Prospect (2019-2030)
1.6.6 South America HER2 Antibody Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa HER2 Antibody Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Genentech Inc
2.1.1 Genentech Inc Details
2.1.2 Genentech Inc Major Business
2.1.3 Genentech Inc HER2 Antibody Product and Solutions
2.1.4 Genentech Inc HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Genentech Inc Recent Developments and Future Plans
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG HER2 Antibody Product and Solutions
2.2.4 Novartis AG HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis AG Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer HER2 Antibody Product and Solutions
2.3.4 Pfizer HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Abnova Corporation
2.4.1 Abnova Corporation Details
2.4.2 Abnova Corporation Major Business
2.4.3 Abnova Corporation HER2 Antibody Product and Solutions
2.4.4 Abnova Corporation HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Abnova Corporation Recent Developments and Future Plans
2.5 InvivoGen
2.5.1 InvivoGen Details
2.5.2 InvivoGen Major Business
2.5.3 InvivoGen HER2 Antibody Product and Solutions
2.5.4 InvivoGen HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 InvivoGen Recent Developments and Future Plans
2.6 Celltrion
2.6.1 Celltrion Details
2.6.2 Celltrion Major Business
2.6.3 Celltrion HER2 Antibody Product and Solutions
2.6.4 Celltrion HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Celltrion Recent Developments and Future Plans
2.7 Biocon Limited
2.7.1 Biocon Limited Details
2.7.2 Biocon Limited Major Business
2.7.3 Biocon Limited HER2 Antibody Product and Solutions
2.7.4 Biocon Limited HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biocon Limited Recent Developments and Future Plans
2.8 Bio-Techne
2.8.1 Bio-Techne Details
2.8.2 Bio-Techne Major Business
2.8.3 Bio-Techne HER2 Antibody Product and Solutions
2.8.4 Bio-Techne HER2 Antibody Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bio-Techne Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global HER2 Antibody Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of HER2 Antibody by Company Revenue
3.2.2 Top 3 HER2 Antibody Players Market Share in 2023
3.2.3 Top 6 HER2 Antibody Players Market Share in 2023
3.3 HER2 Antibody Market: Overall Company Footprint Analysis
3.3.1 HER2 Antibody Market: Region Footprint
3.3.2 HER2 Antibody Market: Company Product Type Footprint
3.3.3 HER2 Antibody Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global HER2 Antibody Consumption Value and Market Share by Type (2019-2024)
4.2 Global HER2 Antibody Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global HER2 Antibody Consumption Value Market Share by Application (2019-2024)
5.2 Global HER2 Antibody Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America HER2 Antibody Consumption Value by Type (2019-2030)
6.2 North America HER2 Antibody Consumption Value by Application (2019-2030)
6.3 North America HER2 Antibody Market Size by Country
6.3.1 North America HER2 Antibody Consumption Value by Country (2019-2030)
6.3.2 United States HER2 Antibody Market Size and Forecast (2019-2030)
6.3.3 Canada HER2 Antibody Market Size and Forecast (2019-2030)
6.3.4 Mexico HER2 Antibody Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe HER2 Antibody Consumption Value by Type (2019-2030)
7.2 Europe HER2 Antibody Consumption Value by Application (2019-2030)
7.3 Europe HER2 Antibody Market Size by Country
7.3.1 Europe HER2 Antibody Consumption Value by Country (2019-2030)
7.3.2 Germany HER2 Antibody Market Size and Forecast (2019-2030)
7.3.3 France HER2 Antibody Market Size and Forecast (2019-2030)
7.3.4 United Kingdom HER2 Antibody Market Size and Forecast (2019-2030)
7.3.5 Russia HER2 Antibody Market Size and Forecast (2019-2030)
7.3.6 Italy HER2 Antibody Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific HER2 Antibody Consumption Value by Type (2019-2030)
8.2 Asia-Pacific HER2 Antibody Consumption Value by Application (2019-2030)
8.3 Asia-Pacific HER2 Antibody Market Size by Region
8.3.1 Asia-Pacific HER2 Antibody Consumption Value by Region (2019-2030)
8.3.2 China HER2 Antibody Market Size and Forecast (2019-2030)
8.3.3 Japan HER2 Antibody Market Size and Forecast (2019-2030)
8.3.4 South Korea HER2 Antibody Market Size and Forecast (2019-2030)
8.3.5 India HER2 Antibody Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia HER2 Antibody Market Size and Forecast (2019-2030)
8.3.7 Australia HER2 Antibody Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America HER2 Antibody Consumption Value by Type (2019-2030)
9.2 South America HER2 Antibody Consumption Value by Application (2019-2030)
9.3 South America HER2 Antibody Market Size by Country
9.3.1 South America HER2 Antibody Consumption Value by Country (2019-2030)
9.3.2 Brazil HER2 Antibody Market Size and Forecast (2019-2030)
9.3.3 Argentina HER2 Antibody Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa HER2 Antibody Consumption Value by Type (2019-2030)
10.2 Middle East & Africa HER2 Antibody Consumption Value by Application (2019-2030)
10.3 Middle East & Africa HER2 Antibody Market Size by Country
10.3.1 Middle East & Africa HER2 Antibody Consumption Value by Country (2019-2030)
10.3.2 Turkey HER2 Antibody Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia HER2 Antibody Market Size and Forecast (2019-2030)
10.3.4 UAE HER2 Antibody Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 HER2 Antibody Market Drivers
11.2 HER2 Antibody Market Restraints
11.3 HER2 Antibody Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 HER2 Antibody Industry Chain
12.2 HER2 Antibody Upstream Analysis
12.3 HER2 Antibody Midstream Analysis
12.4 HER2 Antibody Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global HER2 Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global HER2 Antibody Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global HER2 Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global HER2 Antibody Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Genentech Inc Company Information, Head Office, and Major Competitors
Table 6. Genentech Inc Major Business
Table 7. Genentech Inc HER2 Antibody Product and Solutions
Table 8. Genentech Inc HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Genentech Inc Recent Developments and Future Plans
Table 10. Novartis AG Company Information, Head Office, and Major Competitors
Table 11. Novartis AG Major Business
Table 12. Novartis AG HER2 Antibody Product and Solutions
Table 13. Novartis AG HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis AG Recent Developments and Future Plans
Table 15. Pfizer Company Information, Head Office, and Major Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer HER2 Antibody Product and Solutions
Table 18. Pfizer HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Pfizer Recent Developments and Future Plans
Table 20. Abnova Corporation Company Information, Head Office, and Major Competitors
Table 21. Abnova Corporation Major Business
Table 22. Abnova Corporation HER2 Antibody Product and Solutions
Table 23. Abnova Corporation HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Abnova Corporation Recent Developments and Future Plans
Table 25. InvivoGen Company Information, Head Office, and Major Competitors
Table 26. InvivoGen Major Business
Table 27. InvivoGen HER2 Antibody Product and Solutions
Table 28. InvivoGen HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. InvivoGen Recent Developments and Future Plans
Table 30. Celltrion Company Information, Head Office, and Major Competitors
Table 31. Celltrion Major Business
Table 32. Celltrion HER2 Antibody Product and Solutions
Table 33. Celltrion HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Celltrion Recent Developments and Future Plans
Table 35. Biocon Limited Company Information, Head Office, and Major Competitors
Table 36. Biocon Limited Major Business
Table 37. Biocon Limited HER2 Antibody Product and Solutions
Table 38. Biocon Limited HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Biocon Limited Recent Developments and Future Plans
Table 40. Bio-Techne Company Information, Head Office, and Major Competitors
Table 41. Bio-Techne Major Business
Table 42. Bio-Techne HER2 Antibody Product and Solutions
Table 43. Bio-Techne HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bio-Techne Recent Developments and Future Plans
Table 45. Global HER2 Antibody Revenue (USD Million) by Players (2019-2024)
Table 46. Global HER2 Antibody Revenue Share by Players (2019-2024)
Table 47. Breakdown of HER2 Antibody by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in HER2 Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 49. Head Office of Key HER2 Antibody Players
Table 50. HER2 Antibody Market: Company Product Type Footprint
Table 51. HER2 Antibody Market: Company Product Application Footprint
Table 52. HER2 Antibody New Market Entrants and Barriers to Market Entry
Table 53. HER2 Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global HER2 Antibody Consumption Value (USD Million) by Type (2019-2024)
Table 55. Global HER2 Antibody Consumption Value Share by Type (2019-2024)
Table 56. Global HER2 Antibody Consumption Value Forecast by Type (2025-2030)
Table 57. Global HER2 Antibody Consumption Value by Application (2019-2024)
Table 58. Global HER2 Antibody Consumption Value Forecast by Application (2025-2030)
Table 59. North America HER2 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 60. North America HER2 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 61. North America HER2 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 62. North America HER2 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 63. North America HER2 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 64. North America HER2 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 65. Europe HER2 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Europe HER2 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Europe HER2 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 68. Europe HER2 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 69. Europe HER2 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe HER2 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific HER2 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 72. Asia-Pacific HER2 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 73. Asia-Pacific HER2 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 74. Asia-Pacific HER2 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 75. Asia-Pacific HER2 Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 76. Asia-Pacific HER2 Antibody Consumption Value by Region (2025-2030) & (USD Million)
Table 77. South America HER2 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 78. South America HER2 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 79. South America HER2 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 80. South America HER2 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 81. South America HER2 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 82. South America HER2 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Middle East & Africa HER2 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 84. Middle East & Africa HER2 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 85. Middle East & Africa HER2 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 86. Middle East & Africa HER2 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 87. Middle East & Africa HER2 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 88. Middle East & Africa HER2 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 89. HER2 Antibody Raw Material
Table 90. Key Suppliers of HER2 Antibody Raw Materials
Table 1. Global HER2 Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global HER2 Antibody Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global HER2 Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global HER2 Antibody Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Genentech Inc Company Information, Head Office, and Major Competitors
Table 6. Genentech Inc Major Business
Table 7. Genentech Inc HER2 Antibody Product and Solutions
Table 8. Genentech Inc HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Genentech Inc Recent Developments and Future Plans
Table 10. Novartis AG Company Information, Head Office, and Major Competitors
Table 11. Novartis AG Major Business
Table 12. Novartis AG HER2 Antibody Product and Solutions
Table 13. Novartis AG HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis AG Recent Developments and Future Plans
Table 15. Pfizer Company Information, Head Office, and Major Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer HER2 Antibody Product and Solutions
Table 18. Pfizer HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Pfizer Recent Developments and Future Plans
Table 20. Abnova Corporation Company Information, Head Office, and Major Competitors
Table 21. Abnova Corporation Major Business
Table 22. Abnova Corporation HER2 Antibody Product and Solutions
Table 23. Abnova Corporation HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Abnova Corporation Recent Developments and Future Plans
Table 25. InvivoGen Company Information, Head Office, and Major Competitors
Table 26. InvivoGen Major Business
Table 27. InvivoGen HER2 Antibody Product and Solutions
Table 28. InvivoGen HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. InvivoGen Recent Developments and Future Plans
Table 30. Celltrion Company Information, Head Office, and Major Competitors
Table 31. Celltrion Major Business
Table 32. Celltrion HER2 Antibody Product and Solutions
Table 33. Celltrion HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Celltrion Recent Developments and Future Plans
Table 35. Biocon Limited Company Information, Head Office, and Major Competitors
Table 36. Biocon Limited Major Business
Table 37. Biocon Limited HER2 Antibody Product and Solutions
Table 38. Biocon Limited HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Biocon Limited Recent Developments and Future Plans
Table 40. Bio-Techne Company Information, Head Office, and Major Competitors
Table 41. Bio-Techne Major Business
Table 42. Bio-Techne HER2 Antibody Product and Solutions
Table 43. Bio-Techne HER2 Antibody Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bio-Techne Recent Developments and Future Plans
Table 45. Global HER2 Antibody Revenue (USD Million) by Players (2019-2024)
Table 46. Global HER2 Antibody Revenue Share by Players (2019-2024)
Table 47. Breakdown of HER2 Antibody by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in HER2 Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 49. Head Office of Key HER2 Antibody Players
Table 50. HER2 Antibody Market: Company Product Type Footprint
Table 51. HER2 Antibody Market: Company Product Application Footprint
Table 52. HER2 Antibody New Market Entrants and Barriers to Market Entry
Table 53. HER2 Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global HER2 Antibody Consumption Value (USD Million) by Type (2019-2024)
Table 55. Global HER2 Antibody Consumption Value Share by Type (2019-2024)
Table 56. Global HER2 Antibody Consumption Value Forecast by Type (2025-2030)
Table 57. Global HER2 Antibody Consumption Value by Application (2019-2024)
Table 58. Global HER2 Antibody Consumption Value Forecast by Application (2025-2030)
Table 59. North America HER2 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 60. North America HER2 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 61. North America HER2 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 62. North America HER2 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 63. North America HER2 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 64. North America HER2 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 65. Europe HER2 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Europe HER2 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Europe HER2 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 68. Europe HER2 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 69. Europe HER2 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe HER2 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific HER2 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 72. Asia-Pacific HER2 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 73. Asia-Pacific HER2 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 74. Asia-Pacific HER2 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 75. Asia-Pacific HER2 Antibody Consumption Value by Region (2019-2024) & (USD Million)
Table 76. Asia-Pacific HER2 Antibody Consumption Value by Region (2025-2030) & (USD Million)
Table 77. South America HER2 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 78. South America HER2 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 79. South America HER2 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 80. South America HER2 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 81. South America HER2 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 82. South America HER2 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Middle East & Africa HER2 Antibody Consumption Value by Type (2019-2024) & (USD Million)
Table 84. Middle East & Africa HER2 Antibody Consumption Value by Type (2025-2030) & (USD Million)
Table 85. Middle East & Africa HER2 Antibody Consumption Value by Application (2019-2024) & (USD Million)
Table 86. Middle East & Africa HER2 Antibody Consumption Value by Application (2025-2030) & (USD Million)
Table 87. Middle East & Africa HER2 Antibody Consumption Value by Country (2019-2024) & (USD Million)
Table 88. Middle East & Africa HER2 Antibody Consumption Value by Country (2025-2030) & (USD Million)
Table 89. HER2 Antibody Raw Material
Table 90. Key Suppliers of HER2 Antibody Raw Materials
LIST OF FIGURES
Figure 1. HER2 Antibody Picture
Figure 2. Global HER2 Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global HER2 Antibody Consumption Value Market Share by Type in 2023
Figure 4. Trastuzumab
Figure 5. Lapatinib
Figure 6. Ado-trastuzumab Emtansine
Figure 7. Pertuzumab
Figure 8. Everolimus
Figure 9. Global HER2 Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. HER2 Antibody Consumption Value Market Share by Application in 2023
Figure 11. Hospital Picture
Figure 12. Medical Center Picture
Figure 13. Global HER2 Antibody Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global HER2 Antibody Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market HER2 Antibody Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global HER2 Antibody Consumption Value Market Share by Region (2019-2030)
Figure 17. Global HER2 Antibody Consumption Value Market Share by Region in 2023
Figure 18. North America HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 21. South America HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 23. Global HER2 Antibody Revenue Share by Players in 2023
Figure 24. HER2 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players HER2 Antibody Market Share in 2023
Figure 26. Global Top 6 Players HER2 Antibody Market Share in 2023
Figure 27. Global HER2 Antibody Consumption Value Share by Type (2019-2024)
Figure 28. Global HER2 Antibody Market Share Forecast by Type (2025-2030)
Figure 29. Global HER2 Antibody Consumption Value Share by Application (2019-2024)
Figure 30. Global HER2 Antibody Market Share Forecast by Application (2025-2030)
Figure 31. North America HER2 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 32. North America HER2 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 33. North America HER2 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 34. United States HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe HER2 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe HER2 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe HER2 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 41. France HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific HER2 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific HER2 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific HER2 Antibody Consumption Value Market Share by Region (2019-2030)
Figure 48. China HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 51. India HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 54. South America HER2 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 55. South America HER2 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 56. South America HER2 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa HER2 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa HER2 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa HER2 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 65. HER2 Antibody Market Drivers
Figure 66. HER2 Antibody Market Restraints
Figure 67. HER2 Antibody Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of HER2 Antibody in 2023
Figure 70. Manufacturing Process Analysis of HER2 Antibody
Figure 71. HER2 Antibody Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. HER2 Antibody Picture
Figure 2. Global HER2 Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global HER2 Antibody Consumption Value Market Share by Type in 2023
Figure 4. Trastuzumab
Figure 5. Lapatinib
Figure 6. Ado-trastuzumab Emtansine
Figure 7. Pertuzumab
Figure 8. Everolimus
Figure 9. Global HER2 Antibody Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. HER2 Antibody Consumption Value Market Share by Application in 2023
Figure 11. Hospital Picture
Figure 12. Medical Center Picture
Figure 13. Global HER2 Antibody Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global HER2 Antibody Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market HER2 Antibody Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global HER2 Antibody Consumption Value Market Share by Region (2019-2030)
Figure 17. Global HER2 Antibody Consumption Value Market Share by Region in 2023
Figure 18. North America HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 21. South America HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 23. Global HER2 Antibody Revenue Share by Players in 2023
Figure 24. HER2 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players HER2 Antibody Market Share in 2023
Figure 26. Global Top 6 Players HER2 Antibody Market Share in 2023
Figure 27. Global HER2 Antibody Consumption Value Share by Type (2019-2024)
Figure 28. Global HER2 Antibody Market Share Forecast by Type (2025-2030)
Figure 29. Global HER2 Antibody Consumption Value Share by Application (2019-2024)
Figure 30. Global HER2 Antibody Market Share Forecast by Application (2025-2030)
Figure 31. North America HER2 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 32. North America HER2 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 33. North America HER2 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 34. United States HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe HER2 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe HER2 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe HER2 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 41. France HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific HER2 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific HER2 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific HER2 Antibody Consumption Value Market Share by Region (2019-2030)
Figure 48. China HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 51. India HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 54. South America HER2 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 55. South America HER2 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 56. South America HER2 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa HER2 Antibody Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa HER2 Antibody Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa HER2 Antibody Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE HER2 Antibody Consumption Value (2019-2030) & (USD Million)
Figure 65. HER2 Antibody Market Drivers
Figure 66. HER2 Antibody Market Restraints
Figure 67. HER2 Antibody Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of HER2 Antibody in 2023
Figure 70. Manufacturing Process Analysis of HER2 Antibody
Figure 71. HER2 Antibody Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
